Sign in to continue:

Thursday, March 5th, 2026

CapitaLand India Trust Issues 124,173,000 New Units via Private Placement – Trading Commences on SGX-ST

CapitaLand India Trust Issues 124 Million New Units via Private Placement: Key Investor Details

CapitaLand India Trust Issues 124,173,000 New Units via Private Placement

Key Points for Investors

  • Private Placement Completed: CapitaLand India Trust (“CLINT”) has successfully issued 124,173,000 new units at S\$1.208 per unit through a private placement.
  • Increase in Total Units: Post-issue, the total number of units in issue rises to 1,484,810,733.
  • Trading Commencement: The new units begin trading on the Main Board of the Singapore Exchange Securities Trading Limited (SGX-ST) at 9.00 a.m. on 5 March 2026.
  • Ranking of New Units: The new units rank pari passu with existing units except for the exclusion from CLINT’s distributable income for the period from 1 January 2026 to 4 March 2026. Holders of new units will not be entitled to the Advanced Distribution for this period.

Important Information for Shareholders

  • Distribution Rights: Investors holding the newly issued units will be entitled to CLINT’s distributable income from the day of issuance onwards, and all subsequent distributions. They will not participate in income distributions for the earlier period (1 Jan–4 Mar 2026).
  • Exclusion from Advanced Distribution: This exclusion may be price sensitive as it affects the expected yield for new unit holders in the short term. Investors should factor this into their income projections.
  • Jurisdictional Restrictions: The new units are not being offered or sold in the United States, EEA, UK (except to lawful UK investors), Canada, Japan, or Australia. The securities are not registered in these jurisdictions. Any public offering in the US would require a prospectus, but there will be no such offering.
  • Risk Factors: The announcement includes forward-looking statements, highlighting risks such as industry/economic conditions, interest rate trends, cost and availability of capital, competition, shifting customer demands, operational expenses, regulatory changes, and financing availability. Investors are cautioned not to place undue reliance on these statements.
  • Investment Risks: Units are not guaranteed or insured by the Trustee-Manager or its affiliates. Investment in CLINT is subject to principal risk. Units can only be traded on SGX-ST and are not redeemable by investors while listed.
  • Market Liquidity: Listing on SGX-ST does not guarantee liquidity. Past performance is not indicative of future results.
  • Regulatory Status: This announcement has not been reviewed by the Monetary Authority of Singapore.
  • Product Classification: The new units are prescribed capital markets products and excluded investment products under Singapore regulations.

Potential Impact on Share Price

  • The successful placement and trading of a significant number of new units (over 124 million) could impact CLINT’s share price due to dilution effects and changes in distributable income calculations.
  • The exclusion from the Advanced Distribution for new unit holders may affect short-term yield expectations and could influence investor sentiment.
  • Investors should watch for trading activity and price movements as the new units start trading and as market digests the dilution and new capital raised.

Conclusion

CapitaLand India Trust’s completion of a large private placement is a significant corporate action. Investors must be aware of the dilution, distribution exclusions for new units, and associated risks. This event is likely to be price sensitive, as it affects both the capital structure and short-term income expectations for unitholders.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or an offer to buy or sell securities. All investments carry risk, including the potential loss of principal. Investors should consult their advisors and review all relevant documents before making any investment decision. The information herein is based on official announcements and may be subject to change. This article has not been reviewed by any regulatory authority.


View CapLand India T Historical chart here



V2Y Corporation Updates on Director Felix Ang’s Cessation, Outstanding Sum, and Whistleblowing Investigation 1

V2Y Corporation Faces Boardroom Shakeup: Director Exit, Whistleblower Probe, and S\$506k Dispute Could Impact Shareholder Value Key Highlights Non-Independent Non-Executive Director Mr. Felix Ang has ceased his role at V2Y Corporation Ltd. Ongoing whistleblowing...

Aztech Global’s Malaysia Facility Achieves FDA Registration, Boosting Medical Device Manufacturing for U.S. Market

Key Highlights for Investors FDA Registration Secured: Aztech Global Ltd., via its wholly-owned Malaysian subsidiary IOT Manufacturing Sdn. Bhd. (IOTM), has obtained the Certificate of Registration under the U.S. Food and Drug Administration’s 21...

Ever Glory United Holdings Receives SGX Approval for Public Offer and Mainboard Listing Transfer 12

Ever Glory United Holdings Limited: Key Developments on Public Offer and Mainboard Transfer Ever Glory United Holdings Limited: Receipt of Listing and Quotation Notice for Public Offering & Mainboard Transfer Key Highlights for Investors...

   Ad